Report Finder

All Sentinel reports, surveillance tools, FDA assessments, and communication materials may be searched using the options below. Search results can be further sorted by title, project status, and date posted by clicking on the relevant column header. If you wish to search for FDA Center assessments more specifically by medical product and health outcome, please go to the CDER Assessments and CBER Assessments pages.

E.g., 2/26/2020
E.g., 2/26/2020
Titlesort ascending Status FDA Center Date Posted
Occurrence of Selected Dental HCPCS Codes Complete CDER 01/11/2014
Occurrence of Selected Biological Product HCPCS Codes Complete CBER 10/10/2013
Occurrence of Selected Biological Generic Drug Products Complete CBER 10/10/2013
Occurrence of Kidney Stones Complete CDER 02/25/2014
Nursing Home HCPCS Codes Complete CDER 12/29/2013
Nursing Home Facility HCPCS Codes Complete CDER 01/10/2014
Nucleoside Reverse Transcriptase Inhibitor Procedures Complete CDER 01/07/2013
Non-Melanoma Skin Cancer following Hydrochlorothiazide Use: A Propensity Score Matched Analysis In progress CDER 06/11/2019
Niacin and Niacin Combination Products, Fenofibrates, and Omega-3 Products In progress CDER 10/12/2017
Niacin and Fenofibrate Use and Outcomes with Propensity Score Matching Complete CDER 11/06/2017
New Use of Statins and Rhabdomyolysis Complete CDER 06/30/2016
New Use of Dabigatran or Warfarin and Gastrointestinal Hemorrhage or Intracerebral Hemorrhage Events Complete CDER 06/21/2016
New Use of Anti-Epileptic Drugs and Agranulocytosis Complete CDER 06/21/2016
New Pediatric Users of Leuprolide Acetate Depot Complete CDER 08/17/2018
New Molecular Entities In progress CDER 10/04/2017
Neuropsychiatric Events following Montelukast Use: A Propensity Score Matched Analysis Complete CDER 09/27/2019
Negative Pressure Wound Therapy (NPWT) Procedures Complete CDER 06/08/2012
Natalizumab, Efalizumab, and Progressive Multifocal Leukoencephalopathy (PML) Complete CDER 01/10/2013
Natalizumab and Efalizumab Use Complete CDER 12/13/2012
Mycophenolate Dispensings and Procedures (by Quarter) Complete CDER 12/01/2017
Mycophenolate Dispensings and Procedures In progress CDER 12/01/2017
Multiple Sclerosis Medication Use Complete CDER 01/08/2014
Multiple Sclerosis Medication Injections Complete CDER 01/08/2014
Multiple Births and Preterm Deliveries Complete CDER 05/10/2017
MRI and GBCA Procedures Complete CDER 07/21/2016
Most Frequent Generic Dispensings Among Members Aged 65+ Complete CDER 07/21/2016
Molecularly Targeted Anti-Cancer Therapies Complete CDER 01/24/2018
Mirabegron Use In progress CDER 10/11/2017
Mini-Sentinel: Vaccine Safety Monitoring - Data Characterization Complete 12/27/2013
Mini-Sentinel: Utilization of the DaVinci Device and Other Robotic-Assisted Devices Complete CDRH 01/22/2020
Mini-Sentinel: Two-Dimensional Scan Statistics for Assessing Vaccine Safety in Pregnancy (PRISM) Complete 04/27/2016
Mini-Sentinel: Taxonomy of Observational Study Designs - Phase 3 Complete 11/20/2013
Mini-Sentinel: Taxonomy of Observational Study Designs - Phase 2 Complete 04/09/2012
Mini-Sentinel: Taxonomy of Observational Study Designs - Phase 1 Complete 11/11/2010
Mini-Sentinel: Summary of Antidiabetic Agent Use During Pregnancy Complete CDER 01/02/2020
Mini-Sentinel: Statistical Methods for Improving Confounder Adjustment For Emergent Treatment Comparison Complete 04/22/2014
Mini-Sentinel: Statistical Methods for Estimating Causal Risk Differences (PRISM) Complete 03/07/2012
Mini-Sentinel: Signal Evaluation Methods (Automated) Complete 08/17/2011
Mini-Sentinel: Sequential Testing Methods Complete 08/11/2011
Mini-Sentinel: Safety Signaling Methods for Survival Outcomes to Control for Confounding in the Mini-Sentinel Distributed Database Complete 10/13/2015
Mini-Sentinel: Routine Prospective Safety Surveillance for New Drugs, Vaccines, and Other Biologic Products Complete 04/24/2016
Mini-Sentinel: Re-Use of Mini-Sentinel Data Following Rapid Assessments of Potential Safety Signals Using Customizable Modular Programs Complete 12/04/2012
Mini-Sentinel: Quantifying the Impact of Time-Varying Baseline Risk Adjustment in the Self-Controlled Risk Interval Design (PRISM) Complete 11/04/2015
Mini-Sentinel: Pilot Of Self-Controlled Tree-Temporal Scan Analysis For Gardasil Vaccine Complete 09/30/2016
Mini-Sentinel: Methods to Evaluate Impact of FDA Regulatory Actions Complete 01/24/2013
Mini-Sentinel: Identifying Complementary Data Sources (PRISM) Complete 02/13/2012
Mini-Sentinel: Framework for Assessment of Signal Refinement Positive Results Complete 01/27/2013
Mini-Sentinel: Evaluating Strategies for Data Sharing and Analyses in Distributed Data Settings Complete 01/11/2013
Mini-Sentinel: Equipping PRISM for Pandemic Influenza: Interoperability Specification for Data Partners and Immunization Registries Complete 10/16/2013
Mini-Sentinel: Developing, Implementing, and Testing a Program for High-Dimensional Propensity Score Adjustment in the Mini-Sentinel Distributed Data Environment Complete 10/11/2013
Mini-Sentinel: Continuous versus Group Sequential Analysis for Post-Market Drug and Vaccine Safety Surveillance Complete 03/13/2014
Mini-Sentinel: Collecting Supplemental Information via Two-Phase Study Designs to Investigate Signals Arising from Medication Safety Surveillance Activities Complete 01/14/2014
Mini-Sentinel: Case-Based Methods Complete 10/04/2011
Mini-Sentinel: Birth Certificate Data Matching for the Postlicensure Rapid Immunization Safety Monitoring (PRISM) Program Complete 04/24/2016
Mini-Sentinel: Automated Approaches to Anaphylaxis Case Classification Using Unstructured Data Complete 03/07/2018
Mini-Sentinel: Anonymous Linking of Distributed Databases Complete 09/24/2013
Mini-Sentinel: Analytical Methods to Assess Robustness of Drug Safety Monitoring Results Complete 09/04/2015
Mini-Sentinel: Analytic Methods for Using Laboratory Test Results in Active Database Surveillance Complete 04/12/2017
Mini-Sentinel: 15 Cohorts of Interest for Surveillance Preparedness Complete 05/07/2014
Milk Allergy Diagnoses Complete CDER 05/11/2012
Methotrexate Medication Errors Complete 12/31/2017
Methotrexate and Tofacitinib Use In progress CDER 11/24/2014
Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3 Complete CDER 02/01/2018
Machine Learning Pilot for Electronic Phenotyping of Health Outcomes of Interest In progress 11/14/2018
Lupron Depot-PED Use Among Patients with Central Precocious Puberty Complete CDER 04/15/2019
Long Acting Beta2-Agonists (LABA) Policies and Drug Utilization Patterns Complete CDER 01/09/2014
Lindane Use Summary Table Complete CDER 06/22/2012
Lindane Use Modular Program Complete CDER 01/10/2013
Length of Follow-up Time for New Users of Immunosuppressive Drugs Complete CDER 02/28/2018
Length of Enrollment in Pediatric Population Complete CDER 01/17/2018
Length of Enrollment Among Adolescents after HPV Vaccination Complete CBER 07/06/2016
Laparoscopic Hysterectomy With and Without Robotic Assistance and Adverse Outcomes Complete CDER 06/21/2016
Lap-band Diagnosis Codes Complete CDER 10/20/2014
IVIg Product Use and Hemolysis Events Complete CDER 06/03/2016
IVIg Exposure and Renal Failure Complete CBER 03/07/2015